Clinical Trial Update: Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a combination of polymyxin B sulfate, prednisolone, benzocaine, and clioquinol for eczema (dermatitis eczematous); study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol (combination therapy)

Snippet

Sponsor: EMS | Conditions: Eczema | Phase 3 | Status: COMPLETED